Affiliation:
1. Universidad del Magdalena, Santa Marta, Colombia, Colombia
Abstract
Background:
Cannabis is the most widely used illicit drug worldwide. Although cannabis
can be considered a malignant drug that affects health and produces adverse effects on individuals,
their families and society, it should be noted that therapeutic use has a scientific basis.
Objective:
This study was carried out through a joint methodology that included both the analysis of
patents and scientometrics, with the purpose of constructing a profile for the scientific, inventive and
innovative activity of marijuana in medical uses.
Methodology:
The analyses included indicators based on information about the publication and registration
of scientific articles and patents, as well as impact indicators measured by the citations of the related
publications, facilitating the establishment and understanding of the trends that were identified.
Results:
As a result, it was intended to establish the state of the technologies, processes and research of
this subject to determine whether it is in a state of growth maturity or decline. Additionally, ideas for
novel studies are proposed, and information about countries, offices, authors and reference journals is
shown to serve as a base for innovators, entrepreneurs and new researchers.
Conclusion:
The main contribution of this article is the identification of companies and leading applicants
in the medical use of cannabis, mainly in the formulation of medical preparations, treatments using
these preparations, and heterocyclic compounds present in the Cannabis Sativa plant. Also, potential
markets for the protection of inventions in the field are presented, and a review of outstanding articles
and patents that can be used to know in depth the interests of the main applicants.
Publisher
Bentham Science Publishers Ltd.
Reference17 articles.
1. World drug report 2016 United Nations Office on Drugs and Crime2016
2. Di Forti M.; Morgan C.; Dazzan P.; Pariante C.; Mondelli V.; Marques T.; Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. The Lancet 2015,2,233-238
3. Zuardi A.; Historia del cannabis como medicina: una revisión. Rev Bras Psiquiatr 2006,28,153-157
4. Gobira P.H.; Vilela L.R.; Gonçalves B.D.; Santos R.P.; de Oliveira A.C.; Vieira L.B.; Moreira F.A.; Cannabidiol, a Cannabis sativa constituent, inhibits cocaine-induced seizures in mice: Possible role of the mTOR pathway and reduction in glutamate release. Neurotoxicology 2015,50,116-121
5. Piomelli D.; The molecular logic of endocannabinoid signalling. Nat Rev Neurosciences 2003,4,873-884
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献